A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza



Status:Recruiting
Conditions:Influenza
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:12 - Any
Updated:1/20/2019
Start Date:January 17, 2018
End Date:April 1, 2019
Contact:Stefan Comhaire
Email:stefan.comhaire@romark.com
Phone:813-282-8544

Use our guide to learn which trials are right for you!

Trial to evaluate efficacy and safety of nitazoxanide (NTZ) in the treatment of uncomplicated
influenza.

A multicenter, randomized, double-blind, placebo controlled trial to evaluate efficacy and
safety of nitazoxanide (NTZ) in the treatment of uncomplicated influenza.

Inclusion Criteria:

1. Male and female subjects at least 12 years of age

2. Presence of clinical signs and/or symptoms consistent with an acute illness compatible
with influenza infection (each of the following is required):

1. oral temperature ≥99.4°F or ≥37.4°C (obtained in office or self- measured within
12 hours prior to screening - if self-measured, subjects must also have taken an
antipyretic within 4 hours prior to screening), AND

2. at least one of the following respiratory symptoms (cough, sore throat, nasal
obstruction), AND

3. one of the following constitutional symptoms (fatigue, headache, myalgia,
feverishness).

3. Confirmation of influenza A or B infection in the local community by one of the
following means:

1. the institution's local laboratory,

2. the local public health system,

3. the national public health system, OR

4. a laboratory of a recognized national or multinational influenza surveillance
scheme.

4. Onset of illness no more than 40 hours before enrollment in the trial.

Note: Time of onset of illness is defined as either the earlier of:

1. the time when the temperature was first measured as elevated, OR

2. the time when the subject experienced the presence of at least one respiratory
symptom AND the presence of at least one constitutional symptom.

5. Willing and able to provide written informed consent (including assent by legal
guardian if under 18 years of age) and comply with the requirements of the protocol,
including completion of the patient diary.

Exclusion Criteria:

1. Severity of illness requiring or anticipated to require in-hospital care.

2. Moderate or severe persistent asthma.

3. Cystic fibrosis in children.

4. Stage III or IV (severe or very severe) chronic obstructive pulmonary disease (COPD).

5. Class III or IV congestive heart failure (at least marked limitation of physical
activity in which minimal ordinary activity results in fatigue, palpitation, dyspnea,
or angina pain)

6. Arrhythmia

7. Immunosuppressive disorders or who are receiving immunosuppressive therapy (e.g., for
organ or bone marrow transplants)

8. Untreated HIV infection or treated HIV infection with a CD4 count below 350 cells/mm3
in the last 6 months

9. Persons with sickle cell anemia or other hemoglobinopathies

10. Poorly controlled insulin-dependent diabetes mellitus (HBA1C > 8%)

11. Residents of any age of nursing homes or other long-term care institutions

12. Concurrent infection at the screening examination that requires systemic antimicrobial
therapy.

13. Females of childbearing potential who are either pregnant, breast-feeding or are
sexually active without the use of birth control. Female subjects of child-bearing
potential that are sexually active must have a negative baseline pregnancy test and
must agree to continue an acceptable method of birth control for the duration of the
study and for 1 month post- treatment. A double barrier method, oral birth control
pills administered for at least 2 monthly cycles prior to study drug administration,
an IUD, or medroxyprogesterone acetate administered intramuscularly for a minimum of
one month prior to study drug administration are acceptable methods of birth control
for inclusion into the study. Female subjects are considered of childbearing potential
unless they are postmenopausal (absence of menstrual bleeding for 1 year - or 6 months
if laboratory confirmation of hormonal status), or have had a hysterectomy, bilateral
tubular ligation or bilateral oophorectomy.

14. Receipt of any dose of NTZ, oseltamivir, zanamivir, peramivir, laninamivir, baloxavir,
amantadine or rimantadine within 3 days prior to screening.

15. Prior treatment with any investigational drug therapy within 30 days prior to
screening.

16. Subjects with active respiratory allergies or subjects expected to require
anti-allergy medications during the study period for respiratory allergies.

17. Known sensitivity to NTZ or any of the excipients comprising the NTZ tablets.

18. Subjects unable to take oral medications.

19. Presence of any pre-existing illness that, in the opinion of the Investigator, would
place the subject at an unreasonably increased risk through participation in this
study.

20. Subjects who, in the judgment of the Investigator, will be unlikely to comply with the
requirements of this protocol.
We found this trial at
32
sites
Carrollton, Texas 75010
Phone: 877-925-4642
?
mi
from
Carrollton, TX
Click here to add this to my saved trials
Alabaster, Alabama 35007
?
mi
from
Alabaster, AL
Click here to add this to my saved trials
Anaheim, California 92805
Phone: 877-925-4642
?
mi
from
Anaheim, CA
Click here to add this to my saved trials
Austin, Texas 78735
Phone: 877-925-4642
?
mi
from
Austin, TX
Click here to add this to my saved trials
Birmingham, Alabama 35235
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Brooklyn, New York 11229
Phone: 877-925-4642
?
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Cincinnati, Ohio 45215
Phone: 877-925-4642
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Columbus, Ohio 43214
Phone: 877-925-4642
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Dallas, Texas 75204
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Dayton, Ohio 45424
Phone: 877-925-4642
?
mi
from
Dayton, OH
Click here to add this to my saved trials
Fort Worth, Texas 76107
Phone: 877-925-4642
?
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Goodyear, Arizona 85338
?
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Hoover, Alabama 35216
?
mi
from
Hoover, AL
Click here to add this to my saved trials
Hot Springs, Arkansas 71913
Phone: 877-925-4642
?
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Houston, Texas 77058
Phone: 877-925-4642
?
mi
from
Houston, TX
Click here to add this to my saved trials
Jackson, Tennessee 38305
Phone: 877-925-4642
?
mi
from
Jackson, TN
Click here to add this to my saved trials
Lauderdale Lakes, Florida 33319
Phone: 877-925-4642
?
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Medford, Oregon 97504
Phone: 877-925-4642
?
mi
from
Medford, OR
Click here to add this to my saved trials
Missoula, Montana 59808
Phone: 877-925-4642
?
mi
from
Missoula, MT
Click here to add this to my saved trials
Morayfield, Queensland
?
mi
from
Morayfield,
Click here to add this to my saved trials
New Orleans, Louisiana 70115
Phone: 877-925-4642
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
Orlando, Florida 32819
Phone: 877-925-4642
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Pelham, Alabama 35124
Phone: 877-925-4642
?
mi
from
Pelham, AL
Click here to add this to my saved trials
Pharr, Texas 78577
Phone: 877-925-4642
?
mi
from
Pharr, TX
Click here to add this to my saved trials
Plano, Texas 75024
Phone: 877-925-4642
?
mi
from
Plano, TX
Click here to add this to my saved trials
Rapid City, South Dakota 57702
Phone: 877-925-4642
?
mi
from
Rapid City, SD
Click here to add this to my saved trials
Saint George, Utah 84790
Phone: 877-925-4642
?
mi
from
Saint George, UT
Click here to add this to my saved trials
Saint Louis, Missouri 63141
Phone: 877-925-4642
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Smyrna, Tennessee 37167
?
mi
from
Smyrna, TN
Click here to add this to my saved trials
Tolleson, Arizona 85353
?
mi
from
Tolleson, AZ
Click here to add this to my saved trials
Valparaiso, Indiana 46383
Phone: 877-925-4642
?
mi
from
Valparaiso, IN
Click here to add this to my saved trials
Westminster, California 92683
Phone: 877-925-4642
?
mi
from
Westminster, CA
Click here to add this to my saved trials